Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 21, 2015 7:56 AM ET


Company Overview of Potentia Pharmaceuticals, Inc.

Executive Profile

Henry S. Kaplan M.D.

AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 4 different industries.

See Board Relationships


Dr. Henry J. Kaplan, also known as Hank, M.D. serves as the Chairman of the Department of Ophthalmology and Visual Sciences at the University of Louisville. Dr. Kaplan is a Evans Professor of Ophthalmology. He has led preclinical investigations on the effects of I-con1™ in models of wet AMD. He serves as Director of Health Discovery Corporation. He serves as Member of the Scientific Advisory Board of Potentia Pharmaceuticals, Inc. He serves as Scientific Advisor of Iconic ...

Corporate Headquarters

6400 Westwind Way
Crestwood, Kentucky 40014

United States

Phone: 502-241-4114
Fax: --

Board Members Memberships



Associate's Degree
Columbia University
Weill Cornell Graduate School of Medical Sciences

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Calculated Compensation$4,175

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Valerie Barber Palmieri Chief Executive Officer and President
Vermillion, Inc.
Peter D. Meldrum Ph.D.Chief Executive Officer, President and Director
Myriad Genetics Inc.
Russell Cummings Chief Executive Officer, Executive Director and Member of Investment Committee
Imperial Innovations Group plc
Christopher J. Moreau Chief Executive Officer, President and Non Independent Director
Miraculins Inc.
Jan Groen Ph.D.Chief Executive Officer and Executive Director
MDxHealth SA
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Potentia Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at